ReShape Lifesciences Inc (RSLS) USD0.001
ReShape Lifesciences Inc. is a weight-loss solutions company. The Company is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. Its reshapecare virtual health coaching program is a reimbursed telehealth weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShape Marketplace is an online store, that provides a line of products for bariatric patients. Its ReShape Optimize supplement options include multivitamins, probiotics, calcium, vitamin D, protein and other therapeutic offerings to optimize health. Its ReShape Vest is an investigational, minimally invasive, laparoscopically implanted medical device.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.